Stakeholders’ knowledge, attitudes and practices to pharmacovigilance and adverse drug reaction reporting in clinical trials: a mixed methods study

Simple item page
dc.contributor.authorO'Riordan, David
dc.contributor.authorKinane, Mary
dc.contributor.authorWalsh, Kieran A.
dc.contributor.authorShiely, Frances
dc.contributor.authorEustace, Joe
dc.contributor.authorBermingham, Margaret
dc.contributor.funderHealth Research Boarden
dc.contributor.funderHealth Research Board, Irelanden
dc.date.accessioned2021-10-08T14:57:52Z
dc.date.available2021-10-08T14:57:52Z
dc.date.issued2020-06-07
dc.date.updated2021-10-08T14:14:28Z
dc.description.abstractPurpose: The purpose of this study was to explore the knowledge, attitudes and practices of health professionals working in clinical trials, to pharmacovigilance and adverse drug reaction (ADR) reporting. Methods: A mixed methods study comprising an online questionnaire disseminated from September to November 2018, three semi-structured interviews and four focus groups. The qualitative components were conducted with a random sample of questionnaire participants who had provided their contact details (n = 24). The qualitative interviews were conducted at a location convenient to the participant’s place of work between October and December 2018. Results: One hundred forty-eight participants completed the questionnaire. Study coordinators/project managers represented the largest group of participants ( 28.6%, n = 38). Poor knowledge or understanding of ADR reporting was the most frequently cited barrier to ADR reporting (75%, n = 93). The most common enabler to reporting was having a clear understanding of an ADR definition (85.7%, n = 108). Focus group and interview participants described having limited staff as a barrier to reporting an ADR. They welcomed the prospect of pharmacovigilance training and indicated that face-to-face training would be preferred to provision of online training. Conclusion: This study highlights key factors that influence the reporting of ADRs in clinical trials. Although the findings are specifically related to the clinical trial environment in Ireland, they may provide a useful platform for optimising the future conduct of trials. This research suggests that ADR reporting may be improved through provision of enhanced pharmacovigilance training to clinical trial staff.en
dc.description.statusPeer revieweden
dc.description.versionAccepted Versionen
dc.format.mimetypeapplication/pdfen
dc.identifier.citationO'Riordan, D., Kinane, M., Walsh, K. A., Shiely, F., Eustace, J. and Bermingham, M. (2020) 'Stakeholders’ knowledge, attitudes and practices to pharmacovigilance and adverse drug reaction reporting in clinical trials: a mixed methods study', European Journal of Clinical Pharmacology, 76(10), pp. 1363-1372. doi: 10.1007/s00228-020-02921-0en
dc.identifier.doi10.1007/s00228-020-02921-0en
dc.identifier.endpage1372en
dc.identifier.issn0031-6970
dc.identifier.journaltitleEuropean Journal of Clinical Pharmacologyen
dc.identifier.startpage1363en
dc.identifier.urihttps://hdl.handle.net/10468/12076
dc.identifier.volume76en
dc.language.isoenen
dc.publisherSpringeren
dc.relation.urihttps://link.springer.com/article/10.1007/s00228-020-02921-0
dc.rights© Springer-Verlag GmbH Germany, part of Springer Nature 2020. This is a post-peer-review, pre-copyedit version of an article published in the European Journal of Clinical Pharmacology. The final authenticated version is available online at: http://dx.doi.org/10.1007/s00228-020-02921-0en
dc.subjectAdverse drug reaction reportingen
dc.subjectClinical trialen
dc.subjectPharmacovigilanceen
dc.titleStakeholders’ knowledge, attitudes and practices to pharmacovigilance and adverse drug reaction reporting in clinical trials: a mixed methods studyen
dc.typeArticle (peer-reviewed)en
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
ORiordan_et_al_Pharmacovigilance_and_ADR_reporting_in_clinical_trials.pdf
Size:
308.72 KB
Format:
Adobe Portable Document Format
Description:
Accepted version
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
2.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Pharmacy - Journal Articles